rs63750590
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000021.4(PSEN1):c.488A>G(p.His163Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H163Y) has been classified as Pathogenic.
Frequency
Consequence
NM_000021.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSEN1 | NM_000021.4 | c.488A>G | p.His163Arg | missense_variant | 6/12 | ENST00000324501.10 | NP_000012.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSEN1 | ENST00000324501.10 | c.488A>G | p.His163Arg | missense_variant | 6/12 | 1 | NM_000021.4 | ENSP00000326366.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 15, 2022 | This variant has been identified in multiple unrelated individuals with clinical features associated with Alzheimer disease or dementia. This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database (gnomAD), Cambridge, MA (URL: http://gnomad.broadinstitute.org)). Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 10327206, 12549925, 18045903) - |
not provided, no classification provided | literature only | VIB Department of Molecular Genetics, University of Antwerp | - | - - |
Pick disease;C0338451:Frontotemporal dementia;C1843013:Alzheimer disease 3;C3151038:Acne inversa, familial, 3;C3160720:Dilated cardiomyopathy 1U Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 12, 2021 | - - |
Pick disease;C0338451:Frontotemporal dementia;C1843013:Alzheimer disease 3;C3151038:Acne inversa, familial, 3 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 29, 2021 | This missense change has been observed in individual(s) with early-onset Alzheimer's disease (EOAD) (PMID: 7596406, 8733303, 12433263, 22503161, 26337232, 27264813). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 163 of the PSEN1 protein (p.His163Arg). ClinVar contains an entry for this variant (Variation ID: 18124). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects PSEN1 function (PMID: 8986743, 19111578, 22461631). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PSEN1 protein function. - |
PSEN1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 30, 2023 | The PSEN1 c.488A>G variant is predicted to result in the amino acid substitution p.His163Arg. This variant has previously been reported to be causative for Alzheimer disease in many unrelated individuals (Sherrington et al. 1995. PubMed ID: 7596406; Lohmann et al. 2012. PubMed ID: 22503161). Internally, we have observed this variant in other patients with PSEN1-related disorders. Of note, two different missense variants c.487C>T (p.His163Tyr) and c.488A>C (p.His163Pro), affecting the same amino acid residue, have also been reported to be causative for Alzheimer disease (Alzheimer's Disease Collaborative Group. 1995. PubMed ID: 7550356; HGMD database). Functional studies suggested this variant reduced both Aβ40 and Aβ42 production, but increased Aβ42/Aβ 40 ratio through the effect on γ-secretase (Placanica et al. 2009. PubMed ID: 19036728; Sun et al. 2017. PubMed ID: 27930341). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. In summary, we classify this variant as pathogenic. - |
Alzheimer disease 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 29, 1995 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at